Compounds of formula (I) described herein are both phosphodiesterase 4 (PDE4) enzyme inhibitors and muscarinic M3 receptor antagonists and are useful for the prevention and/or treatment of diseases of the respiratory tract characterized by airway obstruction.
-
Paragraph 0502; 0503; 0504; 0505
(2015/06/17)
HETEROARYL DERIVATIVES FOR THE TREATMENT OF RESPIRATORY DISEASES
The invention relates to novel compounds of formula (I) which are both phosphodiesterase 4 (PDE4) enzyme inhibitors and muscarinic M3 receptor antagonists, methods of preparing such compounds, compositions containing them and therapeutic use thereof.
-
Paragraph 116; 117; 118
(2015/06/18)
PHENYLETHYLPYRIDINE DERIVATIVES AS PDE4-INHIBITORS
The invention relates to novel compounds which are both inhibitors of the phosphodiesterase 4 (PDE4) enzyme and muscarinic M3 receptor antagonists, methods of preparing such compounds, compositions containing them and therapeutic use thereof.
-
Page/Page column 69; 70
(2014/06/24)
NOVEL COMPOUNDS
Compounds of formula (I) defined herein are both inhibitors of the phosphodiesterase 4 (PDE4) enzyme and muscarinic M3 receptor antagonists and are useful for the prevention and/or treatment of a disease of the respiratory tract characterized by airway obstruction.
-
Page/Page column 34
(2014/06/23)
More Articles about downstream products of 1217710-00-3